Factors influencing drug protein binding in patients with end stage renal failure.

作者: R. Vanholder , R. De Smet , S. Ringoir

DOI: 10.1007/BF01428386

关键词:

摘要: Investigations were undertaken to evaluate which uraemic solutes decrease drug protein binding. This was done by performing HPLC-fractionation of biological fluids and studying the effect addition a lyophilisate each fraction normal plasma containing standard quantities radiolabelled drugs. From first study, based only on fractionation ultrafiltrate with an HPLC-gradient mainly aimed at elution hydrophilic compounds, hippuric acid appeared be major binding inhibitor for theophylline phenytoin. The problem this approach that it did not include compounds most substantial Therefore, studies planned fractionate deproteinized sera, but necessary define deproteinisation methods gave highest yields bound ligand. Heat denaturation found one effective methods. When serum, deproteinised method, added plasma, higher capacity displace from sites compared identical volume same samples. Fractionation sample HPLC revealed larger number fractions able inhibit

参考文章(14)
Porter Rd, Cathcart-Rake Wf, Whittier Fc, Grantham Jj, Wan Sh, Secretory activity and aryl acid content of serum, urine, and cerebrospinal fluid in normal and uremic man. Journal of Laboratory and Clinical Medicine. ,vol. 85, pp. 723- ,(1975)
W Cathcart-Rake, R Porter, F Whittier, P Stein, M Carey, J Grantham, Effect of diet on serum accumulation and renal excretion of aryl acids and secretory activity in normal and uremic man The American Journal of Clinical Nutrition. ,vol. 28, pp. 1110- 1115 ,(1975) , 10.1093/AJCN/28.10.1110
Rainer M. Arendt, David J. Greenblatt, Liquid chromatographic retention of β-adrenoceptor antagonists: an index of lipid solubility Journal of Pharmacy and Pharmacology. ,vol. 36, pp. 400- 401 ,(2011) , 10.1111/J.2042-7158.1984.TB04407.X
Thomas A. Depner, Tsutomu Sanaka, Linda A. Stanfel, Suppression of Para-aminohippurate Transport in the Isolated Perfused Kidney by an Inhibitor of Protein Binding in Uremia American Journal of Kidney Diseases. ,vol. 3, pp. 280- 286 ,(1984) , 10.1016/S0272-6386(84)80046-3
J. Ganansia, G. Bianchetti, J.P. Thénot, Correlation between reversed-phase high-performance liquid chromatography and plasma protein binding. Journal of Chromatography B: Biomedical Sciences and Applications. ,vol. 421, pp. 83- 90 ,(1987) , 10.1016/0378-4347(87)80381-X
Paul F. Gulyassy, Albert T. Bottini, Linda A. Stanfel, Elizabeth A. Jarrard, Thomas A. Depner, Isolation and chemical identification of inhibitors of plasma ligand binding. Kidney International. ,vol. 30, pp. 391- 398 ,(1986) , 10.1038/KI.1986.197
Raymond Vanholder, Nadine Van Landschoot, Rike De Smet, Ad Schoots, Severin Ringoir, Drug protein binding in chronic renal failure: Evaluation of nine drugs Kidney International. ,vol. 33, pp. 996- 1004 ,(1988) , 10.1038/KI.1988.99
Peter C. Farrell, Norman L. Grib, DeLoss L. Fry, Robert P. Popovich, Jack W. Broviac, Albert L. Babb, A comparison of in vitro and in vivo solute-protein binding interactions in normal and uremic subjects. Asaio Journal. ,vol. 18, pp. 268- 276 ,(1972) , 10.1097/00002480-197201000-00067
Chen H. Hsu, Raymond Vanholder, Sanjeev Patel, Rita R. De Smet, Patrick Sandra, Severin M.G. Ringoir, Subfractions in uremic plasma ultrafiltrate inhibit calcitriol metabolism Kidney International. ,vol. 40, pp. 868- 873 ,(1991) , 10.1038/KI.1991.287
R. Vanholder, N. Hoefliger, R. De Smet, S. Ringoir, P. Vogeleere, Extraction of protein bound ligands from azotemic sera: Comparison of 12 deproteinization methods Kidney International. ,vol. 41, pp. 1707- 1712 ,(1992) , 10.1038/KI.1992.244